Syncona Portfolio
Latest statistics and disclosures from Syncona Portfolio's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ACHL, AUTL, FRLN, ADAP, and represent 100.00% of Syncona Portfolio's stock portfolio.
- Added to shares of these 1 stocks: FRLN (+$5.1M).
- Syncona Portfolio was a net buyer of stock by $5.1M.
- Syncona Portfolio has $105M in assets under management (AUM), dropping by -0.00%.
- Central Index Key (CIK): 0001725042
Tip: Access up to 7 years of quarterly data
Positions held by Syncona Portfolio consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Syncona Portfolio
Companies in the Syncona Portfolio portfolio as of the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Achilles Therapeutics Sponsored Ads (ACHL) | 53.1 | $56M | 11M | 5.01 | ||
| Autolus Therapeutics Spon Ads (AUTL) | 36.4 | $38M | 7.3M | 5.19 | ||
| Freeline Therapeutics Hldgs Sponsored Ads (FRLN) | 5.6 | $5.8M | +645% | 22M | 0.27 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 4.9 | $5.2M | 1.4M | 3.75 |
Past Filings by Syncona Portfolio
SEC 13F filings are viewable for Syncona Portfolio going back to 2021
- Syncona Portfolio 2022 Q1 filed May 31, 2022
- Syncona Portfolio 2021 Q4 filed Feb. 11, 2022